{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:47:46Z","timestamp":1781246866420,"version":"3.54.1"},"reference-count":37,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2016,10,12]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Sex hormones could provide a future treatment avenue for dry eye post menopause. However, there are few well-controlled studies. This study investigates the impact of testosterone and oestrogen on dry eye symptoms and signs in postmenopausal women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A randomised double-blind placebo-controlled pilot study was conducted involving 40 women with dry eye (age 63.9\u00b15.1\u2005years, 13.2\u00b16.3\u2005years post menopause). Ten women were assigned to each of four treatment groups: transdermal testosterone, oestradiol, testosterone\/oestradiol combination and placebo. Assessment at baseline and after 8\u2005weeks: ocular symptoms, tear osmolarity, tear stability, tear secretion, meibomian gland assessment, corneal and conjunctival sensitivity, serum concentrations of 17\u03b2-oestradiol, 3-\u03b1-androstanediol-glucuronide and dehydroepiandrosterone sulfate. Differences from placebo were examined using one-way analysis of variance and Dunnett's t-test. Within-group analyses included paired t-tests and Spearman correlation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Dryness intensity after 8\u2005weeks was significantly worse in the oestrogen group compared with placebo (p=0.04). No significant changes in other symptoms, tear function, meibomian gland function, lid morphology, corneal or conjunctival sensitivity were observed in any of the groups when compared with the change in placebo after 8\u2005weeks. Within-group analyses showed increased tear secretion in the testosterone\/oestradiol combination group (p=0.03) and a strong association between increased serum androgen and improved tear stability in the testosterone group (\u03c1=0.83,p=0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Oestrogen supplementation may worsen ocular symptoms in postmenopausal women with dry eye, whereas no impact of testosterone therapy on symptoms was apparent. The positive effects of oestrogen and testosterone on tear function require confirmation in a larger study, with sample size calculated from the data generated herein. Placebo control is essential in studies of dry eye therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"www.anzctr.org.au\/ACTRN12612000281897.aspx\" ext-link-type=\"uri\">ACTRN12612000281897<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2016-309498","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T02:10:16Z","timestamp":1478225416000},"page":"926-932","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study"],"prefix":"10.1136","volume":"101","author":[{"given":"Blanka","family":"Golebiowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Badarudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Gerrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"2024092603303479000_101.7.926.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2003.00634.x"},{"key":"2024092603303479000_101.7.926.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00218-6"},{"key":"2024092603303479000_101.7.926.3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/cxo.12147","article-title":"Sex hormones and the dry eye","volume":"97","author":"Truong","year":"2014","journal-title":"Clin Exp Optom"},{"key":"2024092603303479000_101.7.926.4","unstructured":"Sullivan DA . Sex and sex steroid influence on dry eye syndromes. In: Pflugfelder S , Beuerman R , Stern ME, eds . Dry eye and ocular surface disease. New York City, NY: Marcel Dekker Inc., 2004:165\u201390."},{"key":"2024092603303479000_101.7.926.5","first-page":"2632","article-title":"Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome","volume":"35","author":"Sato","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024092603303479000_101.7.926.6","first-page":"3732","article-title":"Androgen influence on the meibomian gland","volume":"41","author":"Sullivan","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024092603303479000_101.7.926.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.12.4874"},{"key":"2024092603303479000_101.7.926.8","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200308000-00006"},{"key":"2024092603303479000_101.7.926.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04217.x"},{"key":"2024092603303479000_101.7.926.10","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.9.1286"},{"issue":"(12 Suppl)","key":"2024092603303479000_101.7.926.11","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/00006324-200112001-00185","article-title":"The efficacy of androgenic artificial tears in the treatment of dry eye","volume":"78","author":"Connor","year":"2001","journal-title":"Optom Vis Sci"},{"key":"2024092603303479000_101.7.926.12","unstructured":"Connor CG . Reduction in dry eye symptoms after treatment with transdermal sex hormone creams. Optom Vis Sci 2007;84:E-abstract 075329."},{"key":"2024092603303479000_101.7.926.13","first-page":"S30","article-title":"A weak androgenic artificial tear solution decreases the osmolarity of dry eye patients","volume":"42","author":"Connor","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024092603303479000_101.7.926.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(00)00181-X"},{"key":"2024092603303479000_101.7.926.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.11.042"},{"key":"2024092603303479000_101.7.926.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304637"},{"key":"2024092603303479000_101.7.926.17","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302705"},{"key":"2024092603303479000_101.7.926.18","first-page":"1553","article-title":"Do sex steroids exert sex-specific and\/or opposite effects on gene expression in lacrimal and meibomian glands?","volume":"15","author":"Sullivan","year":"2009","journal-title":"Mol Vis"},{"key":"2024092603303479000_101.7.926.19","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1458"},{"key":"2024092603303479000_101.7.926.20","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199807000-00002"},{"key":"2024092603303479000_101.7.926.21","doi-asserted-by":"publisher","DOI":"10.1080\/09513590701350390"},{"key":"2024092603303479000_101.7.926.22","doi-asserted-by":"crossref","unstructured":"Golebiowski B , Badarudin N , Eden J , et al . Does endogenous serum oestrogen play a role in Meibomian gland dysfunction in postmenopausal women with dry eye. Br J Ophthalmol Published Online First: 13 Apr 2016. doi:10.1136\/bjophthalmol-2016-308473 doi:10.1136\/bjophthalmol-2016-308473","DOI":"10.1136\/bjophthalmol-2016-308473"},{"key":"2024092603303479000_101.7.926.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.17.2114"},{"key":"2024092603303479000_101.7.926.24","first-page":"158","article-title":"Dry eye in post-menopausal Asian women on hormone replacement therapy","volume":"1","author":"Shaharuddin","year":"2008","journal-title":"Int J Ophthalmol"},{"key":"2024092603303479000_101.7.926.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2006.08.007"},{"key":"2024092603303479000_101.7.926.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb09358.x"},{"key":"2024092603303479000_101.7.926.27","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5359-5_145"},{"key":"2024092603303479000_101.7.926.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554"},{"key":"2024092603303479000_101.7.926.29","doi-asserted-by":"publisher","DOI":"10.1080\/13697130701364644"},{"key":"2024092603303479000_101.7.926.30","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000259"},{"key":"2024092603303479000_101.7.926.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11562.x"},{"key":"2024092603303479000_101.7.926.32","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.5.615"},{"key":"2024092603303479000_101.7.926.33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1253"},{"key":"2024092603303479000_101.7.926.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.11.004"},{"key":"2024092603303479000_101.7.926.35","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000472"},{"key":"2024092603303479000_101.7.926.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.10.032"},{"key":"2024092603303479000_101.7.926.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(02)00316-X"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-309498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:33:44Z","timestamp":1727346824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-309498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,6,26]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bjophthalmol-2016-309498"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309498","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}